Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • gsk

    Tag: gsk

    You Searched For "gsk"
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sept 2019 5:01 PM IST
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 12:54 PM IST
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Medical Dialogues Bureau30 Aug 2019 2:57 PM IST
    These intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
    GSK Belantamab Mafodotin shows to help blood cancer patients

    GSK Belantamab Mafodotin shows to help blood cancer patients

    Medical Dialogues Bureau26 Aug 2019 9:15 AM IST
    Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
    GSK: US pharma president Jack Bailey to step down in December

    GSK: US pharma president Jack Bailey to step down in December

    Medical Dialogues Bureau22 Aug 2019 9:15 AM IST
    Commenting on his time at GSK, Jack Bailey said, "After more than a decade at GSK and nearly three decades in the life sciences industry, I look...
    GSK ends Ebola vaccine RnD; transfers license to US institute

    GSK ends Ebola vaccine RnD; transfers license to US institute

    Medical Dialogues Bureau8 Aug 2019 9:30 AM IST
    GSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Medical Dialogues Bureau3 Aug 2019 9:40 AM IST
    The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    Farhat Nasim2 Aug 2019 9:15 AM IST
    The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
    GSK drug Zejula helps ovarian cancer patients live longer in late-stage study

    GSK drug Zejula helps ovarian cancer patients live longer in late-stage study

    Medical Dialogues Bureau16 July 2019 9:26 AM IST
    GSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Farhat Nasim29 Jun 2019 11:56 AM IST
    The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    Medical Dialogues Bureau27 Jun 2019 9:30 AM IST
    Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
    GSK Pharma to optimise product portfolio to drive growth in India

    GSK Pharma to optimise product portfolio to drive growth in India

    Medical Dialogues Bureau24 Jun 2019 9:19 AM IST
    GSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok